These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
paperSureChEMBL_Manuscript.pdf (877.88 kB)

Identification of the Core Chemical Structure in SureChEMBL Patents

submitted on 28.01.2021, 20:06 and posted on 01.02.2021, 05:20 by Maria J. Falaguera, Jordi Mestres
The SureChEMBL database provides open access to 17 million chemical entities mentioned in 14 million patents published since 1970. However, alongside with molecules covered by patent claims, the database is full of starting materials and intermediate products of little pharmacological relevance. Herein, we introduce a new filtering protocol to automatically select the core chemical structures best representing a congeneric series of pharmacologically relevant molecules in patents. The protocol is first validated against a selection of 890 SureChEMBL patents for which a total of 51,738 manually curated molecules are deposited in ChEMBL. Our protocol was able to select 92.5% of the molecules in ChEMBL from all 270,968 molecules in SureChEMBL for those patents. Subsequently, the protocol was applied to all 240,988 US pharmacological patents for which 9,111,706 molecules are available in SureChEMBL. The unsupervised filtering process selected 5,949,214 molecules (65.3% of the total number of molecules) that form highly congeneric chemical series in 188,795 of those patents (78.3% of the total number of patents).


Email Address of Submitting Author


IMIM Hospital del Mar Medical Research Institute and University Pompeu Fabra



ORCID For Submitting Author


Declaration of Conflict of Interest

No conflict of interest